Skip to content

IMMUNOMEDICS, INC.: filings

Every IMMUNOMEDICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 37 filings, each linked to its SEC index.

Filing record ends 2020-08-05

The latest filing in this captured record is a 10-Q filed 2020-08-05. No later filing is in the SEC companyfacts record captured on 2026-09-22. IMMUNOMEDICS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2020-08-05fiscal Q2 202035970000722830-20-000023
10-Q2020-05-06fiscal Q1 202031670000722830-20-000017
10-K2020-02-27fiscal FY 2019411410000722830-20-000003
10-Q2019-10-30fiscal Q3 201934950000722830-19-000020
10-Q2019-08-07fiscal Q2 201934950000722830-19-000016
10-Q2019-05-09fiscal Q1 201935730000722830-19-000012
10-Q2018-11-07fiscal Q1 201935720000722830-18-000012
10-K2018-08-23fiscal FY 2018361030000722830-18-000006
10-Q2018-05-09fiscal Q3 201833850001558370-18-004502
10-Q2018-02-08fiscal Q2 201830820001558370-18-000528
10-Q2017-11-09fiscal Q1 201830650001558370-17-008736
10-K2017-08-16fiscal FY 2017351000001558370-17-006705
10-Q2017-05-10fiscal Q3 201727750001558370-17-004122
10-Q/A2017-02-10fiscal Q2 201727750001558370-17-000493
10-Q2016-11-02fiscal Q1 201726570001558370-16-009086
10-K2016-08-18fiscal FY 201631900001558370-16-008055
10-Q2016-05-04fiscal Q3 201626760001558370-16-005298
10-Q2016-02-03fiscal Q2 201626740001558370-16-003038
10-Q2015-11-04fiscal Q1 201626570001193125-15-366179
10-K2015-08-19fiscal FY 201531910001193125-15-296226
10-Q2015-05-06fiscal Q3 201525700001193125-15-174666
10-Q2015-02-04fiscal Q2 201525690001193125-15-033714
10-Q2014-11-05fiscal Q1 201525560001193125-14-398630
10-K2014-08-25fiscal FY 2014341150001193125-14-320153
10-Q2014-05-07fiscal Q3 201430850001193125-14-187676
10-Q/A2014-03-19fiscal Q1 201428600001193125-14-104805
10-K/A2014-03-19fiscal FY 2013381420001193125-14-104801
10-Q2014-02-10fiscal Q2 201428730001193125-14-043183
10-Q2013-11-04fiscal Q1 201428600001193125-13-425356
10-K2013-08-22fiscal FY 2013381420001193125-13-343873
10-Q2013-05-08fiscal Q3 201334940001193125-13-207557
10-Q2013-02-07fiscal Q2 201333920001193125-13-043657
10-Q2012-11-08fiscal Q1 201329620001193125-12-460450
10-K2012-08-23fiscal FY 2012381480001193125-12-366797
10-Q2012-05-08fiscal Q3 201233900001193125-12-218535
10-Q2012-02-08fiscal Q2 201233900001193125-12-045285
10-Q2011-11-04fiscal Q1 201228580001193125-11-297450

Inspect the source

Entity
IMMUNOMEDICS, INC. / CIK 0000722830
Captured
SEC response SHA-256
d9e652f20067bb0e424f518a6160c3705c40f702f691a59fdf4f1d40e5e05b37

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000722830.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))